Could cause temporary or reversible harm; serious harm is unlikely.
Failed dissolution specifications: lower than specifications
| Brand name | ATORVASTATIN CALCIUM |
| Generic name | ATORVASTATIN CALCIUM |
| Active ingredient(s) | ATORVASTATIN CALCIUM TRIHYDRATE |
| Distributed by / for | Biocon Pharma Inc., Iselin, NJ 08830-3009 USA |
| NDC | 70377-079-13 |
| Full product label | Atorvastatin Calcium Tablets USP 40 mg, 1000-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA, Manufactured by: Recipharm Pharmaservices PVT, Ltd Bengaluru, INDIA -562-123, NDC 70377-079-13 |
| Recalling firm | BIOCON PHARMA INC |
| Distribution | U.S.A. nationwide |
| Quantity | 2184 bottles |
| Recall initiated | 2025-03-17 |
| Report date | 2025-04-09 |
| Recall completed | — |
| Recall number | D-0306-2025 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | ISELIN NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗